Artiva Biotherapeutics, Inc. ARTV Other Receivables
Other Receivables at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesNetCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s other receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s other receivables?
- Artiva Biotherapeutics, Inc. (ARTV) reported other receivables of $67K in Q4 2025.
- How has Artiva Biotherapeutics, Inc.'s other receivables changed year-over-year?
- Artiva Biotherapeutics, Inc.'s other receivables decreased by 54.1% year-over-year, from $146K to $67K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s other receivables?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s other receivables has grown at a -69.6% compound annual growth rate (CAGR), from $724K to $67K.
- What does other receivables mean?
- This represents miscellaneous claims for cash or other assets not classified under standard trade accounts receivable. It often includes tax refunds, interest receivables, or non-core operational claims. Monitoring this helps identify potential hidden liquidity issues or delays in cash conversion.